1. Mechanistic and therapeutic implications of EphA‐4 receptor tyrosine kinase in the pathogenesis of Alzheimer's disease
   Devargya Ganguly et al, 2022, European Journal of Neuroscience CrossRef
2. Ephrin–Eph receptor tyrosine kinases for potential therapeutics against hepatic pathologies
   Sowmya Mekala et al, 2023, Journal of Cell Communication and Signaling CrossRef
3. EphA4-mediated signaling regulates the aggressive phenotype of irradiation survivor colorectal cancer cells
   Priscila Guimarães de Marcondes et al, 2016, Tumor Biology CrossRef
4. Antibody drug conjugates for treatment of breast cancer: Novel targets and diverse approaches in ADC design
   Pamela A. Trail et al, 2018, Pharmacology & Therapeutics CrossRef
5. Exploring the FGFR3-related oncogenic mechanism in bladder cancer using bioinformatics strategy
   Wei Cao et al, 2017, World Journal of Surgical Oncology CrossRef
6. Targeting Epithelial Mesenchymal Plasticity in Pancreatic Cancer: A Compendium of Preclinical Discovery in a Heterogeneous Disease
   James H. Monkman et al, 2019, Cancers CrossRef
7. Eph family co-expression patterns define unique clusters predictive of cancer phenotype
   Fares Al-Ejeh et al, 2014, Growth Factors CrossRef
8. Chronic Cigarette Smoke Mediated Global Changes in Lung Mucoepidermoid Cells: A Phosphoproteomic Analysis
   Hitendra S. Solanki et al, 2017, OMICS: A Journal of Integrative Biology CrossRef
9. Identification of new EphA4 inhibitors by virtual screening of FDA-approved drugs
   Shuo Gu et al, 2018, Scientific Reports CrossRef
10. Immunotherapy for Breast Cancer Treatment
    Miganoosh Simonian et al, 2021, Iranian Biomedical Journal CrossRef
11. Role of the Family of Ephs and Ephrins in Cell-Cell Communication in Cancer
    Mohamed Amessou et al, 2015, Intercellular Communication in Cancer CrossRef
12. SSX2 regulates focal adhesion but does not drive the epithelial to mesenchymal transition in prostate cancer
    Jordan E. Bloom et al, 2016, Oncotarget CrossRef
13. Serum levels of FAK and some of its effectors in adult AML: correlation with prognostic factors and survival
    Mona G. El-Sisi et al, 2021, Molecular and Cellular Biochemistry CrossRef
14. MicroRNA-335 suppresses the proliferation, migration, and invasion of breast cancer cells by targeting EphA4
    Yilong Dong et al, 2018, Molecular and Cellular Biochemistry CrossRef
15. Emerging Kinase Therapeutic Targets in Pancreatic Ductal Adenocarcinoma and Pancreatic Cancer Desmoplasia
    Justin F. Creeden et al, 2020, International Journal of Molecular Sciences CrossRef
16. hTERT promotes tumor progression by enhancing TSPAN13 expression in osteosarcoma cells
    Rishi K. Jaiswal et al, 2018, Molecular Carcinogenesis CrossRef
17. Transcriptomic Profiling of Tumor-Infiltrating CD4+TIM-3+ T Cells Reveals Their Suppressive, Exhausted, and Metastatic Characteristics in Colorectal Cancer Patients
    Varun Sasidharan Nair et al, 2020, Vaccines CrossRef
18. EphA4-ADAM10 Interplay Patterns the Cochlear Sensory Epithelium through Local Disruption of Adherens Junctions
    Jean Defourny et al, 2019, iScience CrossRef
19. A cancer mutation promotes EphA4 oligomerization and signaling by altering the conformation of the SAM domain
    Taylor P. Light et al, 2021, Journal of Biological Chemistry CrossRef
20. The role of Eph receptors in cancer and how to target them: novel approaches in cancer treatment
    Oscar J Buckens et al, 2020, Expert Opinion on Investigational Drugs CrossRef